These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9257891

  • 1. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM, Koelman CA, Doxiadis II, van Houwelingen JC, Goulmy E, Claas FH.
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [Abstract] [Full Text] [Related]

  • 2. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 3. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F, Brenci S, Ghio M, Bignardi D, Contini P, Bacigalupo A, Van Lint MT, Scudeletti M, Ferrone S, Indiveri F.
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [Abstract] [Full Text] [Related]

  • 4. [Dynamic monitoring of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation by soluble HLA-I antigen detection].
    Xia R, Qiu HY, Zhang WP, Cao Q, Lan JC, Wen HS, Wang JM.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):687-90, 695. PubMed ID: 15958310
    [Abstract] [Full Text] [Related]

  • 5. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [Abstract] [Full Text] [Related]

  • 6. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 7. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
    Sedivá A, Starý J, Hromadníková I, Skalická A, Ghio M.
    Cas Lek Cesk; 2000 Oct 11; 139(20):630-4. PubMed ID: 11192758
    [Abstract] [Full Text] [Related]

  • 8. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY, Kwok J, Lie AK, Chen P, Chen FE, Liang R.
    Haematologica; 2001 Jun 11; 86(6):652-6. PubMed ID: 11418376
    [Abstract] [Full Text] [Related]

  • 9. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y, Japan Marrow Donor Program.
    Br J Haematol; 2007 Apr 11; 137(2):142-51. PubMed ID: 17391494
    [Abstract] [Full Text] [Related]

  • 10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 11; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 11; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 12. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M, Kier P, Spona J, Sebesta C, Tiefengraber E, Habertheuer KH, Ruckser R, Schmid A, Kalhs P, Lechner K.
    Bone Marrow Transplant; 1994 Sep 11; 14(3):403-6. PubMed ID: 7994262
    [Abstract] [Full Text] [Related]

  • 13. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E.
    Bone Marrow Transplant; 1999 Jan 11; 23(2):145-50. PubMed ID: 10197799
    [Abstract] [Full Text] [Related]

  • 14. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A, Barak V, Novick D, Nagler A.
    Cytokines Cell Mol Ther; 1997 Sep 11; 3(3):153-8. PubMed ID: 9426973
    [Abstract] [Full Text] [Related]

  • 15. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.
    Br J Haematol; 2004 Sep 11; 126(5):697-703. PubMed ID: 15327522
    [Abstract] [Full Text] [Related]

  • 16. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.
    Biol Blood Marrow Transplant; 2003 Jan 11; 9(1):52-9. PubMed ID: 12533742
    [Abstract] [Full Text] [Related]

  • 17. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
    de Bueger M, Bakker A, Bontkes H, van Rood JJ, Goulmy E.
    Bone Marrow Transplant; 1993 May 11; 11(5):363-8. PubMed ID: 8504270
    [Abstract] [Full Text] [Related]

  • 18. Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Mauz-Körholz C, Körholz D, Burdach S.
    J Lab Clin Med; 1995 Aug 11; 126(2):144-50. PubMed ID: 7636387
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
    Nagler A, Bishara A, Brautbar C, Barak V.
    Cytokines Cell Mol Ther; 1998 Sep 11; 4(3):161-7. PubMed ID: 9825841
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.